[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 24, Issue 6 (Iranian South Medical Journal 2021) ::
Iran South Med J 2021, 24(6): 637-638 Back to browse issues page
Hypothesis Generation: Does Lu177 Therapy May be Effective for Treatment of Benign Prostate Hyperthrophy?
Mehrshad Abbasi
Department of Nuclear Medicine, Tehran University of Medical Sciences , meabbasi@tums.ac.ir
Abstract:   (196 Views)
It has been decades full of documents to support the effectiveness and safety of I131 therapy for benign and malignant thyroid disease. Benign hyperfunctioning thyroid nodules and post thyroidectomy malignant metastases accumulate I131. Recently Lu177 PSMA has been successfully used for the treatment of prostate cancer metastases. Comparing the thyroid and prostate may bring a theory to treat benign prostate hypertrophy with Lu177 PSMA. Although proceeding to practice needs prior dosimetry study, effectiveness and safety evaluation, and cost-benefits assessment, the idea on its own is interesting.
Keywords: benign prostate hypertrophy, systemic radiation therapy, lutetium
Full-Text [PDF 113 kb]   (57 Downloads)    
Type of Study: Letter to Editor | Subject: Radiology. Diagnostic Imaging
Received: 2022/03/6 | Accepted: 2022/03/16 | Published: 2022/05/7
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Abbasi M. Hypothesis Generation: Does Lu177 Therapy May be Effective for Treatment of Benign Prostate Hyperthrophy?. Iran South Med J. 2021; 24 (6) :637-638
URL: http://ismj.bpums.ac.ir/article-1-1558-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 24, Issue 6 (Iranian South Medical Journal 2021) Back to browse issues page
دانشگاه علوم پزشکی بوشهر، طب جنوب ISMJ

Iranian South Medical Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License which allows users to read,
copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly

Copyright © 2022, Iranian South Medical Journal| All Rights Reserved

Persian site map - English site map - Created in 0.07 seconds with 30 queries by YEKTAWEB 4419